Welcome to The Briefing: Register or log in to tailor our content to your needs

The Briefing is all about showing you what you're most interested in. Personalize the content on The Briefing by choosing exactly what you want to see.

Subject Relevance
Sections

UCL INSTITUTE OF BIOMEDICAL ENGINEERING

Medical Imaging Agents

1 - 10 of 92 items

Study: Using isosmolar contrast agent during angioplasty reduces risk of renal and cardiac events

Significantly fewer renal and cardiac events are associated with angioplasty procedures using isosmolar contrast medium (IOCM) agent Visipaque™ (iodixanol) than those using low-osmolar contrast media (LOCM), demonstrate data from abstracts presented at the EuroPCR Congress 2015 in Paris.

The abstracts… Read more →

silvernanoclusters

Silver nanoclusters inside synthetic DNA have utility in bioimaging

A team of researchers at the University of Calfornia, Santa Barbara (UCSB) has created nanoscale silver clusters with unique fluorescence properties important for bioimaging.

The researchers positioned silver clusters at programmed sites on a nanoscale breadboard, a construction base for… Read more →

Novel Ga-68-PSMA-ligand PET/CT effective for early detection of prostate cancer recurrence

A recent study reported in The Journal of Nuclear Medicine compared use of the novel Ga-68-PSMA-ligand PET/CT with other imaging methods and found that it had substantially higher detection rates of prostate-specific membrane antigen (PSMA) in patients with biochemical recurrence… Read more →

Philips launches innovative 3D navigation system to enhance minimally invasive treatment of vascular disease

Royal Philips (NYSE: PHG, AEX: PHIA) has announced the launch of VesselNavigator*, its latest innovation in live 3D catheter navigation to guide the minimally invasive treatment of patients with vascular diseases such as aortic aneurysms (ballooning of the aorta). This… Read more →

Scientists visualize potential brain cancer treatments in real time with nanotechnology

Virginia Tech Carilion Research Institute scientists have developed new imaging techniques to watch dangerous brain tumor cells respond to treatment in real time.

Published in Nano Letters, the study was led by Zhi Sheng and Deborah Kelly, both assistant professors… Read more →

New fluorescence imaging reagent targets degenerative diseases

Researchers at South Dakota State University (Brookings, SD) developed a fluorescence imaging reagent that will enable better understanding of degenerative diseases (such as Alzheimer’s and Parkinson’s) and perhaps lead to ways to… Read more →

Nanoparticles spice up Alzheimer’s diagnosis

MRI and histochemical staining of mice brains showing Cur-MNP labeled plaques (right) but not in the control group (left).Dementia has a devastating effect on the 40 million sufferers worldwide and costs billions in healthcare. Alzheimer’s disease makes up 60-80% of… Read more →

Engineered fluorescent protein allows study of structure within living cells

Researchers at the RIKEN Brain Science Institute (Wako City, Japan) engineered a fluorescent protein that rapidly assembles into large crystals inside living cells, and showed that cells actively targeted the crystals for degradation. The unprecedented size and purity of these… Read more →

New fluorescent protein views neural activity beyond microscope’s field of view

Researchers at the Howard Hughes Medical Institute (HHMI)’s Janelia Research Campus (Ashburn, VA) have developed a new fluorescent protein that lets scientists shine a light on an animal’s brain to permanently mark neurons that are active at a particular time.… Read more →

Nanovectors combine cancer imaging and therapy

Researchers at Imperial College London and the Laboratoire de chimie de la matière condensée de Paris (CNRS/Collège de France/UPMC) have designed and developed hybrid gold-silica nanoparticles, which are turning out to be genuine therapeutic “Swiss Army knives”. Tested in mice… Read more →

Cookies on IBME website

Our website uses cookies to provide us with important information about visitors. By continuing to browse the site we'll assume that you are happy to receive all cookies set by IBME.